INFINITY PHARMACEUTICALS, INC. Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2010 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Infinity Pharmaceuticals, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2010 to Q2 2023.
  • Infinity Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2023 was -$9.96M, a 16.9% increase year-over-year.
  • Infinity Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2023 was -$40.9M, a 12.5% increase year-over-year.
  • Infinity Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$44.4M, a 1.97% increase from 2021.
  • Infinity Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$45.3M, a 11.8% decline from 2020.
  • Infinity Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2020 was -$40.5M, a 14% increase from 2019.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 -$40.9M -$9.96M +$2.03M +16.9% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-10
Q1 2023 -$43M -$11M +$1.39M +11.2% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-09
Q4 2022 -$44.4M -$9.23M +$2.42M +20.8% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-28
Q3 2022 -$46.8M -$10.7M -$4K -0.04% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-14
Q2 2022 -$46.8M -$12M -$717K -6.36% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 -$46.1M -$12.4M -$807K -6.94% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 -$45.3M -$11.7M -$1.05M -9.93% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-28
Q3 2021 -$44.2M -$10.7M -$1.18M -12.4% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$43M -$11.3M -$1.8M -19% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 -$41.2M -$11.6M -$743K -6.83% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-03
Q4 2020 -$40.5M -$10.6M +$783K +6.88% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-29
Q3 2020 -$41.3M -$9.53M +$1.88M +16.5% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-02
Q2 2020 -$43.2M -$9.47M +$1.04M +9.9% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-27
Q1 2020 -$44.2M -$10.9M +$2.86M +20.8% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 -$47.1M -$11.4M -$3.16M -38.5% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-16
Q3 2019 -$43.9M -$11.4M -$24.8M -185% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 -$19.1M -$10.5M -$3.55M -51% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-30
Q1 2019 -$15.5M -$13.7M -$4.29M -45.4% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 -$11.3M -$8.22M -$923K -12.6% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-03
Q3 2018 -$10.3M $13.4M +$20.5M Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-30
Q2 2018 -$30.8M -$6.96M +$9.99M +58.9% Apr 1, 2018 Jun 30, 2018 10-Q 2019-07-30
Q1 2018 -$40.8M -$9.45M +$1.02M +9.78% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-07
Q4 2017 -$41.8M -$7.3M +$15.6M +68.2% Oct 1, 2017 Dec 31, 2017 10-K 2018-03-15
Q3 2017 -$57.5M -$7.1M +$12.4M +63.6% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-05
Q2 2017 -$69.9M -$17M -$69.9M -132% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-07
Q1 2017 $88K -$10.5M +$30.2M +74.2% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-08
Q4 2016 -$30.1M -$22.9M +$16.3M +41.5% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-15
Q3 2016 -$46.4M -$19.5M -$62M -146% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-15
Q2 2016 $15.7M $53M +$91.4M Apr 1, 2016 Jun 30, 2016 10-K 2018-03-15
Q1 2016 -$75.7M -$40.7M +$52.6M +56.4% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-15
Q4 2015 -$128M -$39.2M +$1.15M +2.86% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-14
Q3 2015 -$130M $42.5M -$60.7M -58.8% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-14
Q2 2015 -$68.9M -$38.4M -$404K -1.06% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-14
Q1 2015 -$68.5M -$93.3M -$51M -121% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-14
Q4 2014 -$17.4M -$40.3M -$7.42M -22.5% Oct 1, 2014 Dec 31, 2014 10-K 2016-02-23
Q3 2014 -$10M $103M +$137M Jul 1, 2014 Sep 30, 2014 10-K 2016-02-23
Q2 2014 -$147M -$38M -$5.43M -16.7% Apr 1, 2014 Jun 30, 2014 10-K 2016-02-23
Q1 2014 -$142M -$42.3M -$14.9M -54.7% Jan 1, 2014 Mar 31, 2014 10-K 2016-02-23
Q4 2013 -$127M -$32.9M +$14.1M +29.9% Oct 1, 2013 Dec 31, 2013 10-K 2015-02-24
Q3 2013 -$141M -$33.9M -$52.3M -284% Jul 1, 2013 Sep 30, 2013 10-K 2015-02-24
Q2 2013 -$88.5M -$32.6M -$17.9M -122% Apr 1, 2013 Jun 30, 2013 10-K 2015-02-24
Q1 2013 -$70.6M -$27.3M -$16.6M -155% Jan 1, 2013 Mar 31, 2013 10-K 2015-02-24
Q4 2012 -$54M -$47M -$32.9M -234% Oct 1, 2012 Dec 31, 2012 10-K 2014-02-25
Q3 2012 -$21M $18.4M +$30.3M Jul 1, 2012 Sep 30, 2012 10-K 2014-02-25
Q2 2012 -$51.4M -$14.7M -$2.93M -25% Apr 1, 2012 Jun 30, 2012 10-K 2014-02-25
Q1 2012 -$48.5M -$10.7M -$8.42M -365% Jan 1, 2012 Mar 31, 2012 10-K 2014-02-25
Q4 2011 -$40M -$14.1M Oct 1, 2011 Dec 31, 2011 10-K 2013-03-05
Q3 2011 -$11.9M +$9.01M +43% Jul 1, 2011 Sep 30, 2011 10-K 2013-03-05
Q2 2011 -$11.7M -$5.79M -97.4% Apr 1, 2011 Jun 30, 2011 10-K 2013-03-05
Q1 2011 -$2.31M Jan 1, 2011 Mar 31, 2011 10-K 2013-03-05
Q3 2010 -$21M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-08
Q2 2010 -$5.94M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.